Full View

The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan

WC Cheng, YC Shen, CR Chien, WC Liao… - Thoracic …, 2022 - Wiley Online Library
Background The treatment options for epidermal growth factor receptor (EGFR)‐mutated
non‐small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR‐tyrosine …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from …

WC Cheng, YC Shen, CR Chien, WC Liao… - Thoracic …, 2022 - ncbi.nlm.nih.gov
Background The treatment options for epidermal growth factor receptor (EGFR)‐mutated
non‐small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR‐tyrosine …

The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan

WC Cheng, YC Shen, CR Chien, WC Liao… - Thoracic …, 2022 - search.proquest.com
Background The treatment options for epidermal growth factor receptor (EGFR)‐mutated
non‐small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR‐tyrosine …

The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from Taiwan

WC Cheng, YC Shen, CR Chien, WC Liao… - Thoracic …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The treatment options for epidermal growth factor receptor (EGFR)-mutated non-
small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR-tyrosine kinase …

The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from Taiwan.

WC Cheng, YC Shen, CR Chien, WC Liao… - Thoracic …, 2022 - europepmc.org
Background The treatment options for epidermal growth factor receptor (EGFR)-mutated non-
small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR-tyrosine kinase …